# RBPJL

## Overview
RBPJL is a gene that encodes the recombination signal binding protein for immunoglobulin kappa J region-like, a transcription factor predominantly expressed in pancreatic acinar cells. This protein is a critical component of the PTF1 complex, which is essential for the transcriptional regulation of genes involved in the production of digestive enzymes. Unlike its paralog RBPJ, RBPJL does not interact with the Notch signaling pathway, instead playing a unique role in repressing Notch target genes through its interaction with the corepressor SHARP. The protein's activity is primarily nuclear, where it binds to specific DNA sequences to modulate transcription, thereby influencing cell differentiation and development. RBPJL's function is vital for maintaining normal digestive processes and metabolic homeostasis, and its dysregulation has been implicated in various diseases, including cancer and inflammatory conditions (Nair2018Functional; Pan2021Transcription).

## Function
RBPJL is a transcription factor primarily expressed in pancreatic acinar cells, where it plays a crucial role in the development and maintenance of the exocrine pancreas. It is a component of the PTF1 complex, which regulates the expression of digestive enzymes necessary for nutrient breakdown (Nair2018Functional). RBPJL is involved in the transcriptional regulation of genes such as Cel and Ctrb, which are important for pancreatic function and glucose homeostasis (Nair2018Functional).

In healthy cells, RBPJL functions by forming a complex with PTF1a and E-proteins to promote the transcription of acinar-specific digestive enzymes, maintaining acinar cell identity (Pan2021Transcription). It binds to the same DNA sequences as its paralog RBPJ but does not respond to Notch activation, instead repressing Notch target gene expression by interacting with the corepressor SHARP (Pan2021Transcription). This interaction is crucial for its role in gene repression, as RBPJL can compensate for RBPJ's repression capabilities in the absence of RBPJ (Pan2021Transcription).

RBPJL's activity is primarily nuclear, where it binds DNA to modulate transcription, influencing cell differentiation and development (Pan2021Transcription). Its role in regulating pancreatic enzyme expression is significant for maintaining normal digestive processes and metabolic homeostasis.

## Clinical Significance
Mutations and alterations in the RBPJL gene have been implicated in various diseases, particularly in the context of cancer and inflammatory conditions. In esophageal squamous cell carcinoma (ESCC), the RBPJL (p.P476S) mutation has been shown to significantly impair the efficacy of anti-PD-1 therapy, such as toripalimab, by blunting T-cell responses. This mutation decreases the expression and secretion of IL-16, a cytokine crucial for T-cell chemotaxis, proliferation, and differentiation, thereby reducing the infiltration of CD4+ and CD8+ T cells into tumors and allowing continued tumor growth (Miao2020p.P476S).

In acute pancreatitis (AP), RBPJL is poorly expressed, and its re-expression can mitigate the inflammatory response by downregulating the Arid5a/IL-6/STAT3 signaling pathway. This pathway is known to contribute to the progression of AP, and RBPJL's role in inhibiting this axis suggests its potential as a therapeutic target. Overexpression of RBPJL in pancreatic acinar cells has been associated with reduced inflammation, decreased apoptosis, and improved cell viability, highlighting its protective role against pancreatic damage (Lv2022Blockade).

## Interactions
RBPJL is a transcription factor that plays a significant role in pancreatic development and function. It is a component of the PTF1 complex, which is crucial for the transcriptional activation of acinar-specific genes. The PTF1 complex initially includes RBPJ but transitions to include RBPJL during the development of pancreatic acinar cells. This switch is essential for the activation of digestive enzyme genes, as RBPJL binds to DNA at specific sites characterized by E-box and TC-box sequences, facilitating transcriptional activation (Masui2007Early).

RBPJL does not interact with NotchIC, unlike its paralog RBPJ, indicating distinct functional roles. Instead, RBPJL is involved in the PTF1-L complex, which is active in acinar cells and is responsible for the transcription of digestive enzymes (kulic2010novel). RBPJL also interacts with the Arid5a/IL-6/STAT3 axis in the context of acute pancreatitis, where it binds to the promoter region of Arid5a, down-regulating its expression and thereby repressing the IL-6/STAT3 signaling pathway. This interaction is crucial for reducing inflammation in pancreatic acinar cells (Lv2022Blockade).


## References


1. (kulic2010novel) Iva Kulic. A novel role for the Notch effector RBPJ in tumorigenesis. PhD thesis, University of British Columbia, 2010. This article has 0 citations.

[2. (Masui2007Early) Toshihiko Masui, Qiaoming Long, Thomas M. Beres, Mark A. Magnuson, and Raymond J. MacDonald. Early pancreatic development requires the vertebrate suppressor of hairless (rbpj) in the ptf1 bhlh complex. Genes &amp; Development, 21(20):2629–2643, October 2007. URL: http://dx.doi.org/10.1101/gad.1575207, doi:10.1101/gad.1575207. This article has 133 citations.](https://doi.org/10.1101/gad.1575207)

[3. (Lv2022Blockade) Jiachen Lv, Min Fang, Shijie Sun, Gang Wang, Songbin Fu, Bei Sun, and Jinxue Tong. Blockade of the arid5a/il-6/stat3 axis underlies the anti-inflammatory effect of rbpjl in acute pancreatitis. Cell &amp; Bioscience, June 2022. URL: http://dx.doi.org/10.1186/s13578-022-00819-1, doi:10.1186/s13578-022-00819-1. This article has 5 citations.](https://doi.org/10.1186/s13578-022-00819-1)

[4. (Pan2021Transcription) Leiling Pan, Philipp Hoffmeister, Aleksandra Turkiewicz, N. Huynh, Andreas Große-Berkenbusch, Uwe Knippschild, J. Gebhardt, Bernd Baumann, Tilman Borggrefe, and Franz Oswald. Transcription factor rbpjl is able to repress notch target gene expression but is non-responsive to notch activation. Cancers, 13(19):5027, October 2021. URL: http://dx.doi.org/10.3390/cancers13195027, doi:10.3390/cancers13195027. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13195027)

[5. (Nair2018Functional) Anup K. Nair, Jeff R. Sutherland, Michael Traurig, Paolo Piaggi, Peng Chen, Sayuko Kobes, Robert L. Hanson, Clifton Bogardus, and Leslie J. Baier. Functional and association analysis of an amerindian-derived population-specific p.(thr280met) variant in rbpjl, a component of the ptf1 complex. European Journal of Human Genetics, 26(2):238–246, January 2018. URL: http://dx.doi.org/10.1038/s41431-017-0062-6, doi:10.1038/s41431-017-0062-6. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-017-0062-6)

[6. (Miao2020p.P476S) Lei Miao, Xiao‐Li Wei, Qi Zhao, JingJing Qi, Chao Ren, Qi‐Nian Wu, Da‐Liang Wei, Jia Liu, Feng‐Hua Wang, and Rui‐Hua Xu. P.p476s mutation of rbpjl inhibits the efficacy of anti‐pd‐1 therapy in oesophageal squamous cell carcinoma by blunting t‐cell responses. Clinical &amp; Translational Immunology, January 2020. URL: http://dx.doi.org/10.1002/cti2.1172, doi:10.1002/cti2.1172. This article has 1 citations.](https://doi.org/10.1002/cti2.1172)